FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Isoproterenol Hydrochloride | .004 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Ketamine Hydrochloride | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Labetalol Hydrochloride | 5 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Lidocaine Hydrochloride | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | Methadone Hydrochloride | 10 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-781 | 70004-781-40 | Norepinephrine Bitartrate | .016 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-785 | 70004-785-40 | Norepinephrine Bitartrate | .064 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-784 | 70004-784-40 | Norepinephrine Bitartrate | .032 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | Oxytocin | 30 U/500 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Oxytocin | 30 U/500 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-811 | 70004-811-40 | Phenylephrine Hydrochloride | .04 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-040 | 70004-040-06 | Atropine Sulfate | .4 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-811 | 70004-811-12 | Phenylephrine Hydrochloride | .04 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-805 | 70004-805-40 | Phenylephrine Hydrochloride | .4 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-806 | 70004-806-40 | Phenylephrine Hydrochloride | .2 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-12 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-22 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-11 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-807 | 70004-807-40 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-808 | 70004-808-40 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | Phenylephrine Hydrochloride | 40 mg/250 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-816 | 70004-816-12 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | Potassium Chloride | 40 meq/250 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Potassium Chloride | 20 meq/250 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-850 | 70004-850-09 | Rocuronium Bromide | 10 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-850 | 70004-850-12 | Rocuronium Bromide | 10 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | Succinylcholine Chloride | 20 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Succinylcholine Chloride | 20 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-900 | 70004-900-25 | Trisodium Citrate Dihydrate | 40 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 2 g/500 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.75 g/500 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1 g/250 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Vancomycin Hydrochloride | 1.5 g/500 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-540 | 70004-540-35 | Diltiazem Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-541 | 70004-541-35 | Diltiazem Hydrochloride | 1 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-605 | 70004-605-09 | Ephedrine Sulfate | 10 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-604 | 70004-604-12 | Ephedrine Sulfate | 5 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-604 | 70004-604-09 | Ephedrine Sulfate | 5 mg/1 mL | 2023-1 | valid | 2026-11-08 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | "potassium Phosphate, Dibasic; Potassium Phosphate, Monobasic" | 15 mmol/250 mL; 15 mmol/250 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Epinephrine | .032 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Epinephrine | .02 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Epinephrine | .016 mg/1 mL | 2023-1 | source_no_ndc | 2026-11-08 |